Surrozen, Inc. Form 8-K Summary
Business Context and Reporting Period
Surrozen, Inc. filed this Current Report on Form 8-K on December 11, 2023, reporting actions taken at a December 7, 2023 special stockholder meeting and a related reverse stock split. The filing does not present quarterly or annual financial results.
Key Financial and Capital Structure Information
- Voting shares: 30,575,047 shares of common stock were entitled to vote; 17,005,402 shares were present in person or by proxy.
- Reverse stock split: The Board approved a one-for-fifteen (1:15) reverse stock split, effective December 13, 2023.
- Par value: Remains unchanged at $0.0001 per share.
- Warrants: Each 15 shares issuable under outstanding warrants will convert into one share after the split. The warrant exercise price will increase from $11.50 to $172.50 per share.
- Fractional shares: No fractional shares will be issued; eligible holders will receive cash in lieu of fractional shares, subject to applicable warrant terms.
- Revenue, profit, cash flow, margins, debt and liquidity: The filing text does not provide clear values for these metrics.
Material Changes and Stockholder Vote
Stockholders approved an amendment to the certificate of incorporation authorizing a reverse stock split. The vote was 16,220,409 for, 784,459 against and 534 abstentions. The Board subsequently selected the 1:15 ratio from the alternative ratios approved by stockholders.
The split will also proportionately reduce shares available under equity incentive and employee stock purchase plans and adjust the number of shares and exercise prices applicable to outstanding options, restricted stock units and warrants.
Outlook, Risks and Unusual Items
- The common stock was scheduled to begin trading on a split-adjusted basis on Nasdaq under the existing ticker symbol SRZN when the market opened on December 14, 2023.
- The new common-stock CUSIP is 86889P208.
- The warrants continue trading under SRZNW, with post-split adjustments to their share coverage and exercise price.
- The reverse split may affect per-share trading prices, share counts, equity-plan awards and warrant economics; the filing does not provide an estimate of these market effects.
- No revenue guidance, operating outlook, liquidity forecast or other management forecast is included.
Important Facts for Investors to Verify
- Confirm the December 13, 2023 effective date and December 14, 2023 split-adjusted trading date.
- Verify the 1:15 conversion ratio and treatment of fractional shares.
- Review the adjusted share counts, option and restricted-stock-unit terms, and warrant terms after the split.
- Confirm the post-split warrant exercise price of $172.50 and the new common-stock CUSIP.
- Consult the company’s periodic SEC filings for current cash, debt, liquidity, operating results and financing requirements, which are not provided in this 8-K.